Further characterization of hepatic tryptophan pyrrolase inhibition by zymosan.
D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology; D000242:Cyclic AMP / Q000494:pharmacology; D003593:Cytoplasm / Q000187:drug effects; D066298:In Vitro Techniques; D008099:Liver / Q000201:enzymology*; D008628:Mercury / Q000494:pharmacology; D008706:Methemoglobin / Q000494:pharmacology; D051379:Mice; D008928:Mitochondria / Q000187:drug effects; D014366:Tryptophan Oxygenase / Q000037:antagonists & inhibitors*; D015054:Zymosan / Q000494:pharmacology*
D008706:Methemoglobin; D015054:Zymosan; D000242:Cyclic AMP; D014366:Tryptophan Oxygenase; D008628:Mercury; D001205:Ascorbic Acid